تعديل

Affichage des articles dont le libellé est BioCryst's lead drug for rare genetic disorder fails study. Afficher tous les articles
Affichage des articles dont le libellé est BioCryst's lead drug for rare genetic disorder fails study. Afficher tous les articles

lundi 8 février 2016

BioCryst's lead drug for rare genetic disorder fails study

(Reuters) - Drug developer BioCryst Pharmaceuticals Inc said its lead drug for a rare genetic condition had failed in a large trial to reduce the frequency of recurrent swelling in patients.











http://ift.tt/1W62nwk

from Reuters: Health News
via animenewspro